FTC orders Ottobock to divest Freedom Innovations acquisition

The U.S. Federal Trade Commission ordered Ottobock to divest the assets obtained from Freedom Innovations, saying the merger would weaken competition in the market for computer-controlled prosthetic knees.

“The Commission is committed to ensuring competitive markets for the benefit of consumers.”fiercebiotech.com

• 1 source
• fiercebiotech.comFTC orders artificial limb maker Ottobock to undo and divest its knee acquisition | Fierce BiotechConor HaleNov 7, 2019

Summarized from public sources; check the original articles before acting on it.